Eosin Y used to formulate Eosin Y aqueous is in the form of the disodium salt. The free acid has very limited solubility in water, generally around 0.08%. The free acid is sometimes referred to as spirit-soluble, as the dye has somewhat higher solubilities in alcohol or alcohol.
HT110216
Eosin Y Solution, Aqueous
Skip To
form
solution
shelf life
Expiry date on the label.
IVD
for in vitro diagnostic use
concentration
0.5 % (w/v) in water
application(s)
hematology
histology
storage temp.
room temp
Quality Level
Looking for similar products? Visit Product Comparison Guide
1 of 4
This Item | HT110280 | HT110232 | HT1101128 |
|---|---|---|---|
| concentration 0.5 % (w/v) in water | concentration 0.5 % (w/v) in water | concentration 0.5 % (w/v) in water | concentration 0.5 % (w/v) in acidified ethanol |
| form solution | form solution | form solution | form solution |
| application(s) hematology | application(s) hematology | application(s) hematology | application(s) hematology |
| Quality Level 500 | Quality Level 500 | Quality Level 500 | Quality Level 500 |
| IVD for in vitro diagnostic use | IVD for in vitro diagnostic use | IVD for in vitro diagnostic use | IVD for in vitro diagnostic use |
| shelf life Expiry date on the label. | shelf life Expiry date on the label. | shelf life Expiry date on the label. | shelf life Expiry date on the label. |
Application
General purpose cytoplasmic counterstain. Used with hematoxylin and eosin staining.
Other Notes
Certified Eosin Y, 0.5% (w/v) in water. Not acidified.
Storage Class
10 - Combustible liquids
wgk
WGK 2
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves, multi-purpose combination respirator cartridge (US)
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Frederik Denorme et al.
Blood, 127(19), 2337-2345 (2016-03-02)
Rapid vascular recanalization forms the basis for successful treatment of cerebral ischemia. Currently, tissue plasminogen activator (t-PA) is the only approved thrombolytic drug for ischemic stroke. However, t-PA does not always result in efficient thrombus dissolution and subsequent blood vessel
Kenneth C Valkenburg et al.
Oncotarget, 8(46), 80265-80277 (2017-11-09)
Prostate cancer is the most diagnosed non-skin cancer in the US and kills approximately 27,000 men per year in the US. Additional genetic mouse models are needed that recapitulate the heterogeneous nature of human prostate cancer. The Wnt/beta-catenin signaling pathway
Senna Staessens et al.
Haematologica, 105(2), 498-507 (2019-05-03)
Ischemic stroke is caused by a thromboembolic occlusion of cerebral arteries. Treatment is focused on fast and efficient removal of the occluding thrombus, either via intravenous thrombolysis or via endovascular thrombectomy. Recanalization, however, is not always successful and factors contributing
Vincent W Yang et al.
Molecular cancer research : MCR, 17(1), 165-176 (2018-08-16)
Krüppel-like factor 4 (KLF4), a zinc finger transcription factor, regulates homeostasis of the intestinal epithelium. Previously, it was reported that KLF4 functions as a tumor suppressor in colorectal cancer. Here, evidence demonstrates that KLF4 mitigates the development and progression of
Majken Siersbæk et al.
Scientific reports, 7, 40220-40220 (2017-01-11)
Epigenetic factors have been suggested to play an important role in metabolic memory by trapping and maintaining initial metabolic changes within the transcriptional regulatory machinery. In this study we fed mice a high fat diet (HFD) for seven weeks followed
-
What are the components of Eosin Y solution (cat# HT110216)? Is it made out of Eosin Y disodium salt (C20H6Br4Na2O5) or Eosin Y (C20H6Br4O5)?
1 answer-
Helpful?
-
Active Filters
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service